Clinical Trial Update: Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers [Phase 2, Phase 3]

View source ↗

Summary

This Phase 2/3 trial evaluated Cediranib plus placebo with cisplatin/gemcitabine versus placebo with cisplatin/gemcitabine in advanced biliary tract cancers; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cediranib (Cediranib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University College, London | Conditions: Biliary Tract Neoplasms | Phase 2, Phase 3 | Status: COMPLETED